Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents | Zendy

Ahmed N. Mahmoud | Zendy; Amr F. Barakat | Zendy; Akram Y. Elgendy | Zendy; Erik Schneibel | Zendy; Amgad Mentias | Zendy; Ahmed AbuZaid | Zendy; Islam Y. Elgendy | Zendy

Open Access

Long-Term Efficacy and Safety of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents

Author(s) -

Ahmed N. Mahmoud,

Amr F. Barakat,

Akram Y. Elgendy,

Erik Schneibel,

Amgad Mentias,

Ahmed AbuZaid,

Islam Y. Elgendy

Publication year - 2017

Publication title -

circulation cardiovascular interventions

Language(s) - English

Resource type - Journals

eISSN - 1941-7632

pISSN - 1941-7640

DOI - 10.1161/circinterventions.117.005286

Subject(s) - everolimus , medicine , myocardial infarction , target lesion , stent , relative risk , revascularization , thrombosis , lesion , cardiology , surgery , confidence interval , percutaneous coronary intervention

Data regarding the long-term efficacy and safety of everolimus-eluting bioresorbable vascular scaffolds (BVS) compared with everolimus-eluting stents are limited. This meta-analysis aimed to compare the long-term outcomes with both devices.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research